NCT00585078View on ClinicalTrials.gov

Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic Adenocarcinoma

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 31, 2004

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions

Pancreatic Cancer

Interventions

DRUG

Capecitabine

DRUG

Oxaliplatin

Trial Locations (1)

02115

Beth Israel Deaconess Medical Center, Boston

Sponsors

Collaborators (1)

All Listed Sponsors

lead

Beth Israel Deaconess Medical Center

OTHER

collaborator

Sanofi

INDUSTRY